METTL6 and hepatocellular carcinoma: METTL6 catalyzes the formation of 3-methylcytidine at the C32 site of a specific serine tRNA heteroreceptor, and deletion of METTL6 leads to changes in ribosome occupancy and RNA levels, as well as impaired pluripotency in HCC [38].